Alignment Healthcare (NASDAQ:ALHC) Shares Gap Down – Here’s What Happened

Alignment Healthcare, Inc. (NASDAQ:ALHC) gapped down before the market opened on Friday . The stock had previously closed at $18.61, but opened at $15.50. Alignment Healthcare shares last traded at $14.9210, with a volume of 2,128,841 shares.

Alignment Healthcare News Roundup

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Alignment Healthcare reported second-quarter adjusted earnings of $0.17 per share, exceeding the $0.13 analyst consensus and improving from $0.07 a year earlier. Revenue increased 31.6% year over year to $1.34 billion, above the $1.31 billion estimate. Alignment Healthcare Beats Q2 Earnings and Revenue Estimates
• Positive Sentiment: Management said it surpassed the high end of guidance across key second-quarter metrics. Net income more than doubled to $36.6 million as medical-care costs in its Medicare Advantage plans eased, suggesting improved cost control and operating leverage. Alignment Healthcare Turns Profit as Insurer Gets Handle on Costs
• Neutral Sentiment: Full-year 2026 revenue guidance was maintained at approximately $5.2 billion, while third-quarter revenue guidance of roughly $1.3 billion was broadly in line with analyst expectations. The update did not provide a clearly stronger outlook to drive a positive earnings reaction. Alignment Healthcare Reports Second Quarter 2026 Results
• Negative Sentiment: Several law firms, including Block & Leviton, Kaplan Fox, Lowey Dannenberg and Pomerantz, announced investigations into potential securities-law violations and solicited investors who suffered losses. These announcements do not establish wrongdoing, but they create legal and reputational uncertainty and may be contributing to selling pressure. Block and Leviton Alignment Healthcare Investigation

Analysts Set New Price Targets

Several analysts have commented on ALHC shares. Wolfe Research started coverage on shares of Alignment Healthcare in a research report on Friday, April 17th. They issued an “outperform” rating and a $24.00 price objective on the stock. Weiss Ratings raised shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. UBS Group reaffirmed a “neutral” rating on shares of Alignment Healthcare in a report on Wednesday, July 8th. Finally, Barclays lowered their price target on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. Six analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, Alignment Healthcare has an average rating of “Moderate Buy” and a consensus price target of $24.30.

Alignment Healthcare Price Performance

The business’s 50-day moving average price is $19.73 and its 200 day moving average price is $19.80. The company has a market capitalization of $3.34 billion, a P/E ratio of 180.07, a price-to-earnings-growth ratio of 2.47 and a beta of 1.05. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 1.56.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The company had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.31 billion. During the same quarter last year, the company earned $0.07 earnings per share. The firm’s quarterly revenue was up 31.6% on a year-over-year basis. Analysts anticipate that Alignment Healthcare, Inc. will post 0.2 EPS for the current fiscal year.

Insider Activity at Alignment Healthcare

In related news, insider Mark D. Kent acquired 14,848 shares of Alignment Healthcare stock in a transaction that occurred on Tuesday, June 2nd. The stock was bought at an average price of $13.31 per share, with a total value of $197,626.88. Following the transaction, the insider directly owned 14,848 shares in the company, valued at approximately $197,626.88. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $24.00, for a total value of $600,000.00. Following the completion of the transaction, the executive vice president directly owned 1,103,816 shares of the company’s stock, valued at approximately $26,491,584. This represents a 2.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,039,951 shares of company stock valued at $19,976,967 over the last 90 days. Company insiders own 5.20% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Handelsbanken Fonder AB lifted its stake in Alignment Healthcare by 85.7% during the 2nd quarter. Handelsbanken Fonder AB now owns 55,700 shares of the company’s stock valued at $1,326,000 after acquiring an additional 25,700 shares during the period. GAMMA Investing LLC raised its holdings in shares of Alignment Healthcare by 46.6% during the second quarter. GAMMA Investing LLC now owns 3,368 shares of the company’s stock valued at $80,000 after purchasing an additional 1,070 shares during the last quarter. Versant Capital Management Inc lifted its position in Alignment Healthcare by 463.3% during the second quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock valued at $33,000 after purchasing an additional 1,135 shares during the period. Bank of America Corp DE lifted its position in Alignment Healthcare by 156.5% during the first quarter. Bank of America Corp DE now owns 3,215,667 shares of the company’s stock valued at $56,660,000 after purchasing an additional 1,961,778 shares during the period. Finally, Edgestream Partners L.P. purchased a new stake in Alignment Healthcare in the first quarter worth approximately $4,852,000. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.